Rankings
▼
Calendar
ARVN FY 2016 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$856M
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
Gross Profit
$7M
100.0% margin
Operating Income
-$16M
-247.0% margin
Net Income
-$14M
-215.2% margin
EPS (Diluted)
$-7.56
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$525,586
Balance Sheet
Total Assets
$38M
Total Liabilities
$14M
Stockholders' Equity
$24M
Cash & Equivalents
$5M
← Q1 2017
All Quarters